ArticleNeoplasia (New York, N.Y.)2025

Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents.

Rocco Caggiano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.